UI111
/ Korea United Pharm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 09, 2026
Study to Evaluate the Safety and the Pharmacokinetics of "UI111" and "UIC202006" Under Fed Conditions
(clinicaltrials.gov)
- P1 | N=44 | Completed | Sponsor: Korea United Pharm. Inc.
New P1 trial • Dyslipidemia • Metabolic Disorders
1 to 1
Of
1
Go to page
1